-
1
-
-
0038031723
-
International Society of Hypertension (ISH): Statement on blood pressure lowering and stroke prevention
-
Chalmers J, Todd A, Chapman N, et al.: International Society of Hypertension (ISH): Statement on blood pressure lowering and stroke prevention. J Hypertens 2003, 21: 651-663.
-
(2003)
J Hypertens
, vol.21
, pp. 651-663
-
-
Chalmers, J.1
Todd, A.2
Chapman, N.3
-
2
-
-
23344449697
-
Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study
-
Mancia G, Ambrosioni E, Rosei EA, et al.: Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study. J Hypertens 2005, 23: 1575-1581.
-
(2005)
J Hypertens
, vol.23
, pp. 1575-1581
-
-
Mancia, G.1
Ambrosioni, E.2
Rosei, E.A.3
-
3
-
-
34250350040
-
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25: 1105-1187.
-
(2007)
J Hypertens
, vol.25
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
-
4
-
-
33745956809
-
Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council
-
Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council. Circulation 2006, 113: e873-e923.
-
(2006)
Circulation
, vol.113
-
-
Goldstein, L.B.1
Adams, R.2
Alberts, M.J.3
-
5
-
-
0036623822
-
Secondary prevention of stroke: Old and new evidence
-
Mancia G, Grassi G: SecondOry prevention of stroke: old and new evidence. Aging Clin Exp Res 2002, 14: 216-220.
-
(2002)
Aging Clin Exp Res
, vol.14
, pp. 216-220
-
-
Mancia, G.1
Grassi, G.2
-
6
-
-
52249116778
-
Telmisartan to prevent recurrent stroke and cardiovascular events
-
for PRoFESS Study Group:
-
Yusuf S, Diener HC, Sacco RL, et al.; for PRoFESS Study Group: Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008, 359: 1225-1237.
-
(2008)
N Engl J Med
, vol.359
, pp. 1225-1237
-
-
Yusuf, S.1
Diener, H.C.2
Sacco, R.L.3
-
7
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
-
Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991, 22: 983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
8
-
-
0343273397
-
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts
-
Prospective Studies Collaboration:
-
Prospective Studies Collaboration: Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995, 346: 1647-1653.
-
(1995)
Lancet
, vol.346
, pp. 1647-1653
-
-
-
9
-
-
0025234906
-
Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
-
MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335: 765-774.
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
-
10
-
-
0027469656
-
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data
-
Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153: 598-615.
-
(1993)
Arch Intern Med
, vol.153
, pp. 598-615
-
-
Stamler, J.1
Stamler, R.2
Neaton, J.D.3
-
11
-
-
0028306578
-
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
-
Collins R, MacMahon S: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994, 50: 272-298.
-
(1994)
Br Med Bull
, vol.50
, pp. 272-298
-
-
Collins, R.1
MacMahon, S.2
-
12
-
-
0036600393
-
Systolic blood pressure: An underestimated cardiovascular risk factor
-
Mancia G, SeravalleAG, Grassi G: Systolic blood pressure: an underestimated cardiovascular risk factor. J Hypertens 2002, 20(Suppl 5): S21-S27.
-
(2002)
J Hypertens
, vol.20
, Issue.SUPPL. 5
-
-
Mancia, G.1
Seravalle, G.2
Grassi, G.3
-
13
-
-
0032885836
-
Isolated systolic hypertension: Prognostic information provided by pulse pressure
-
Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension: Prognostic information provided by pulse pressure. Hypertension 1999, 34: 375-380.
-
(1999)
Hypertension
, vol.34
, pp. 375-380
-
-
Domanski, M.J.1
Davis, B.R.2
Pfeffer, M.A.3
-
14
-
-
0031683011
-
Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects
-
Benetos A, Rudnichi A, Safar M, Guize L: Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998, 32: 560-564.
-
(1998)
Hypertension
, vol.32
, pp. 560-564
-
-
Benetos, A.1
Rudnichi, A.2
Safar, M.3
Guize, L.4
-
15
-
-
0030745808
-
Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly?
-
Nielsen WB, Lindenstrom E, Vestbo J, Jensen GB: Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens 1997, 10: 634-639.
-
(1997)
Am J Hypertens
, vol.10
, pp. 634-639
-
-
Nielsen, W.B.1
Lindenstrom, E.2
Vestbo, J.3
Jensen, G.B.4
-
16
-
-
0012666855
-
Aortic stiffness is an independent predictor of fatal stroke in essential hypertension
-
Laurent S, Katsahian S, Fassot C, et al.: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34: 1203-1206.
-
(2003)
Stroke
, vol.34
, pp. 1203-1206
-
-
Laurent, S.1
Katsahian, S.2
Fassot, C.3
-
17
-
-
0033613192
-
Association between local pulse pressure, mean blood pressure, and large-artery remodelling
-
Boutouyrie P, Bussy C, Lacolley P, et al.: Association between local pulse pressure, mean blood pressure, and large-artery remodelling. Circulation 1999, 100: 1387-1393.
-
(1999)
Circulation
, vol.100
, pp. 1387-1393
-
-
Boutouyrie, P.1
Bussy, C.2
Lacolley, P.3
-
18
-
-
0027958469
-
Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study
-
D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB: Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994, 25: 40-43.
-
(1994)
Stroke
, vol.25
, pp. 40-43
-
-
D'Agostino, R.B.1
Wolf, P.A.2
Belanger, A.J.3
Kannel, W.B.4
-
19
-
-
0037130648
-
New evidence for stroke prevention: Scientific review
-
Straus SE, Majumdar SR, McAlister FA: New evidence for stroke prevention: Scientific review. JAMA 2002, 288: 1388-1395.
-
(2002)
JAMA
, vol.288
, pp. 1388-1395
-
-
Straus, S.E.1
Majumdar, S.R.2
McAlister, F.A.3
-
20
-
-
0035922695
-
Cardiovascular protection and blood pressure reduction: A meta-analysis
-
Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001, 358: 1305-1315.
-
(2001)
Lancet
, vol.358
, pp. 1305-1315
-
-
Staessen, J.A.1
Wang, J.G.2
Thijs, L.3
-
21
-
-
0031439427
-
Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence
-
for the INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators:
-
Gueyffier F, Boissel JP, Boutitie F, et al., for the INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators: Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. Stroke 1997, 28: 2557-2562.
-
(1997)
Stroke
, vol.28
, pp. 2557-2562
-
-
Gueyffier, F.1
Boissel, J.P.2
Boutitie, F.3
-
22
-
-
0035968623
-
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
-
PROGRESS Collaborative Group:
-
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358: 1033-1041.
-
(2001)
Lancet
, vol.358
, pp. 1033-1041
-
-
-
23
-
-
0028811682
-
Post-stroke antihypertensive treatment study. A preliminary result
-
PATS Collaborating Group:
-
PATS Collaborating Group: Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 1995, 108: 710-717.
-
(1995)
Chin Med J (Engl)
, vol.108
, pp. 710-717
-
-
-
24
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
for the Heart Outcomes Prevention Evaluation Study Investigators:
-
Yusuf S, Sleight P, Pogue J, et al., for the Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342: 145-153.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
-
25
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
for the HOT Study Group:
-
Hansson L, Zanchetti A, Carruthers SG, et al., for the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351: 1755-1762.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
-
26
-
-
0033281522
-
Blood pressure control in type 2 diabetes-What does the United Kingdom Prospective Diabetes Study (UKPDS) tell us?
-
Bilous R: Blood pressure control in type 2 diabetes-What does the United Kingdom Prospective Diabetes Study (UKPDS) tell us? Nephrol Dial Transplant 1999, 14: 2562-2564.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 2562-2564
-
-
Bilous, R.1
-
27
-
-
0012391671
-
Treatment of hypertension and the J curve
-
Hansson L: Treatment of hypertension and the J curve. J Clin Hypertens (Greenwich) 1999, 1: 136-140.
-
(1999)
J Clin Hypertens (Greenwich)
, vol.1
, pp. 136-140
-
-
Hansson, L.1
-
28
-
-
0033528524
-
Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials
-
Gueyffier F, Bulpitt C, Boissel JP, et al.: Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Lancet 1999, 353: 793-796.
-
(1999)
Lancet
, vol.353
, pp. 793-796
-
-
Gueyffier, F.1
Bulpitt, C.2
Boissel, J.P.3
-
29
-
-
10744233011
-
Results of the pilot study for the Hypertension in the Very Elderly Trial
-
Bulpitt CJ, Beckett NS, Cooke J, et al.: Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003, 21: 2409-2417.
-
(2003)
J Hypertens
, vol.21
, pp. 2409-2417
-
-
Bulpitt, C.J.1
Beckett, N.S.2
Cooke, J.3
-
30
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators:
-
Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350: 757-764.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, L.3
-
31
-
-
0036668188
-
Systolic and diastolic blood pressure control in antihypertensive drug trials
-
Mancia G, Grassi G: Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002, 20: 1461-1464.
-
(2002)
J Hypertens
, vol.20
, pp. 1461-1464
-
-
Mancia, G.1
Grassi, G.2
-
32
-
-
0032984862
-
Excess stroke among hypertensive men and women attributable to under-treatment of hypertension
-
Klungel OH, Stricker BH, Paes AH, et al.: Excess stroke among hypertensive men and women attributable to under-treatment of hypertension. Stroke 1999, 30: 1312-1318.
-
(1999)
Stroke
, vol.30
, pp. 1312-1318
-
-
Klungel, O.H.1
Stricker, B.H.2
Paes, A.H.3
-
33
-
-
0032543897
-
Survival in treated hypertension: Follow up study after two decades
-
Andersson OK, Almgren T, Persson B, et al.: Survival in treated hypertension: Follow up study after two decades. BMJ 1998, 317: 167-171.
-
(1998)
BMJ
, vol.317
, pp. 167-171
-
-
Andersson, O.K.1
Almgren, T.2
Persson, B.3
-
34
-
-
0041384377
-
Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population
-
Benetos A, Thomas F, Bean KE, Guize L: Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens 2003, 21: 1635-1640.
-
(2003)
J Hypertens
, vol.21
, pp. 1635-1640
-
-
Benetos, A.1
Thomas, F.2
Bean, K.E.3
Guize, L.4
-
35
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
-
Hansson L, Lindholm LH, Niskanen L, et al.: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353: 611-616.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
-
36
-
-
0344373794
-
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
37
-
-
0037534905
-
The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial
-
Lithell H, Hansson L, Skoog I, et al.: The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003, 21: 875-886.
-
(2003)
J Hypertens
, vol.21
, pp. 875-886
-
-
Lithell, H.1
Hansson, L.2
Skoog, I.3
-
38
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002, 359: 995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
-
39
-
-
52149090673
-
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis
-
Reboldi G, Angeli F, Cavallini C, et al.: Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis. J Hypertens 2008, 26: 1282-1289.
-
(2008)
J Hypertens
, vol.26
, pp. 1282-1289
-
-
Reboldi, G.1
Angeli, F.2
Cavallini, C.3
-
40
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, et al.: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997, 349: 747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
-
41
-
-
0034612118
-
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
-
Pitt B, Poole-Wilson PA, Segal R, et al.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - he Losartan Heart Failure Survival Study ELITE II. Lancet 2000, 355: 1582-1587.
-
(2000)
Lancet
, vol.355
, pp. 1582-1587
-
-
Pitt, B.1
Poole-Wilson, P.A.2
Segal, R.3
-
42
-
-
7444237666
-
Diabetics Exposed to Telmisartan and Enalapril Study Group: Angiotensinreceptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
-
Barnett AH, Bain SC, Bouter P, et al.; Diabetics Exposed to Telmisartan and Enalapril Study Group: Angiotensinreceptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004, 351: 1952-1961.
-
(2004)
N Engl J Med
, vol.351
, pp. 1952-1961
-
-
Barnett, A.H.1
Bain, S.C.2
Bouter, P.3
-
43
-
-
0037036971
-
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan
-
Dickstein K, Kjekshus J: Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002, 360: 752-760.
-
(2002)
Lancet
, vol.360
, pp. 752-760
-
-
Dickstein, K.1
Kjekshus, J.2
-
44
-
-
0242490542
-
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
-
Pfeffer MA, McMurray JJ, Velazquez EJ, et al.: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003, 349: 1893-1906.
-
(2003)
N Engl J Med
, vol.349
, pp. 1893-1906
-
-
Pfeffer, M.A.1
McMurray, J.J.2
Velazquez, E.J.3
-
45
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
Yusuf S, Teo KK, Pogue J, et al.: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358: 1547-1559.
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
-
46
-
-
34147116836
-
Blood pressure-dependent and independent effects of agents that inhibit the rennin-angiotensin system
-
Blood Pressure Lowering Treatment Trialists' Collaboration
-
Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, et al.: Blood pressure-dependent and independent effects of agents that inhibit the rennin-angiotensin system. J Hypertens 2007, 25: 951-958.
-
(2007)
J Hypertens
, vol.25
, pp. 951-958
-
-
Turnbull, F.1
Neal, B.2
|